Zong Li Zhang
Directeur/Membre du Conseil chez VANFUND URBAN INVESTMENT AND DEVELOPMENT CO., LTD.
Provenance du réseau au premier degré de Zong Li Zhang
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Packaged Software | 15 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Zong Li Zhang via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| PENGQI TECHNOLOGY DEVELOPMENT CO., LTD. | Industrial Machinery | Chairman | |
| Southwest University | College/University | Undergraduate Degree | |
Wisefund Investment Holding Group Co., Ltd.
 Wisefund Investment Holding Group Co., Ltd. Real Estate DevelopmentFinance Wisefund Investment Holding Group Co., Ltd. is an investment holding company based in China. The Chinese company has interests in real estate development and mining, among other industries. Bin Hang has been the CEO of the company since 2004. | Real Estate Development | President | |
| TIBET AIM PHARM. INC. | Pharmaceuticals: Other | Director/Board Member | |
Harbin Zhudinggongda New Materials Technology Co., Ltd.
 Harbin Zhudinggongda New Materials Technology Co., Ltd. Other Metals/MineralsNon-Energy Minerals Harbin Zhudinggongda New Materials Technology Co., Ltd. is a company that manufactures non-ferrous metal alloy materials. The company is based in Harbin, China. The Chinese company was founded in 2015. The CEO is Da Wei Xing. | Other Metals/Minerals | Director/Board Member | |
Jilin Wanfang Baiao Biotechnology Co., Ltd.
 Jilin Wanfang Baiao Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Vanfund Urban Investment & Development Co., Ltd., Jilin Wanfang Baiao Biotechnology Co., Ltd. manufactures and sells pharmaceutical products. The company is based in Changchun, China. The Chinese company was founded in 2020. The CEO is Feng Chun Qi. Jilin Wanfang Baiao Biotechnology Co. was acquired by Vanfund Urban Investment & Development Co., Ltd. on January 26, 2022 for $3.29 million. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member |
Statistiques
Internationale
| Chine | 6 |
| Etats-Unis | 2 |
Sectorielle
| Health Technology | 3 |
| Producer Manufacturing | 2 |
| Consumer Services | 2 |
| Finance | 2 |
| Non-Energy Minerals | 2 |
Opérationnelle
| Director/Board Member | 16 |
| Chairman | 4 |
| Corporate Secretary | 4 |
| Independent Dir/Board Member | 4 |
| Chief Executive Officer | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| Yu Liu | 3 |
| Xing Gang Xiao | 3 |
| Hui Zhang | 2 |
| Zi Bin Guo | 2 |
| Zhi Wang Chen | 2 |
| Han Hui Zhang | 2 |
| Jun Zhang | 1 |
| Na Ni | 1 |
| Chun Jing Wei | 1 |
| Ge Lin Liu | 1 |
| Jian Qing Su | 1 |
| Wei Qiang Song | 1 |
| Li Li Sun | 1 |
| Xin Yi Wang | 1 |
| Yan Liu | 1 |
- Bourse
- Insiders
- Zong Li Zhang
- Connexions Sociétés
